2025 Speakers
Ivo Abraham, Professor Of Pharmacy Practice And Science, University of Arizona
Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center
Teresa Ai, Director of Early Product Marketing, Stealth
Anupam Aich, Product Definition Lead, Clinical AI/ML Algorithms, Digital Pathology, Roche
Tero-Pekka Alastalo, CEO, Avenue Biosciences
Krishna Allamneni, EVP, CDO, Concarlo Therapeutics
Sonia Appel, Founder and Principal, Alismere
Audrey Arjomandi, Senior Principal Scientist, Genentech
Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc
Fouad Atouf, Senior VP, Global Biologics, USP
Fouad Atouf, Senior VP, Global Biologics, USP
Aniket Badkar, Director, Formulation and Drug Product Development, Vir Biotechnology, Inc.
Julio Baez, Bioengineering Industrial Advisor, University of California San Diego
Brenda Baker, Head of Scientific Communications, Medical Affairs, Ionis Pharmaceuticals
Amrita Basu, Associate Professor in Surgery, University of California San Francisco
Matthew Bernett, Executive Director, Protein Engineering, Xencor, Inc.
Eddy Berthier, Principal Scientist in Pharmaceutical Development, Integrated Biologics, Lonza
Shiva Bhowmik, Chief Scientific Officer, Trio Pharmaceutials, Inc.
Natalija Budimir, Scientific Engagement LEad, Johnson & Johnson
Iwona Budnicki, Manager, Cellular Immunology, Genovac
Craig Burton, Executive Director, Biosimilars Council
Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics
Steven Calciano, MDM, SCIEX
Allyson Capili, Scientist, Amgen
Prasun Chakraborty, Founder and Chief Executive Officer, Genevation LTD
Melody Chang, VP of Pharmacy Operations, American oncology network
Javier Chaparro-Riggers, Executive Director, Pfizer
David Chen, Senior Director, Pharmacy Operations, Clinical Utilization and Intelligence, The Permanente Medical Group Inc
Qiang Chen, Professor, Biodesign Institute at Arizona State University
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Xiaocheng Chen, Vice President, Antibody Therapeutics, Virtuoso Therapeutics
barry chester, director, pfizer
Judy Chou, President and CEO, AltruBio, Inc.
Daniel Chung, Chief Medical Officer, SparingVision
Hillel Cohen, Scientific Advisor, The Biosimilars Forum
Pamela Contag, Chief Executive Officer, BioEclipse Therapeutics at Open Medicine Institute
Brittney Cottrell, San Diego State University
Ildiko Csiki, CMO, Geneos Therapeutics, Inc.
Douglas da Silva, Director, Absci
Brandon DeKosky, Associate Professor, Massachusetts Institute of Technology / The Ragon Institute
Brad Delaney, Associate Manager, Business Development, Nona Biosciences
Andrew DiChiara, Senior Scientist II, AbbVie
Koen Dierckx, Co-founder and CEO Simabs, simAbs
Robert Dillman, Chief Medical Officer, AIVITA Biomedical, Inc.
Hana Do, Research Analyst, Tufts Center for the Study of Drug Development
Raymond Donninger, Senior Director, Commercial Development, Integrated Biologics, Lonza
Rebecca Driscoll, Co-Founder & CEO, Cancer Help Desk
Ashley Driscoll-Kani, Associate Director Regulatory Affairs, Intercept Pharma
Mary Dwyer, Director, Kactus
Amir Emadzadeh, Director, Genentech
Wendy Epstein, Professor of Law and Associate Dean of Research and Faculty Developmen, Depaul University College Of Law
Reza Farahani, CEO, Katalyze AI
Mourad Farouk Rezk, Global Head Of Medical And Development, Biosimilars, Biogen
Susan Flaker, Director of therapeutic Strategy, Mayo Clinic
Ruby (Madison) Ford, Research Analyst, Tufts University
Amber Freed, Chief Executive Officer and Founder, SLC6A1 Connect
Gordon Freeman, Researcher, Dana Farber Cancer Institute
Pete Fronte, President/CEO, Altura
Joseph Fuhr, Adjunct Faculty, Johns Hopkins University
Shanelle Gabriel, Lupus Patient Advocate, Poet, and Performer, Independant
MariJo Gallina, Senior Director, Cellanome
Armine Galstyan, Head of North America Operations and Principal, SmartGateVC
Amitabh Gaur, President / Senior Scientific Advisor, Innovative Assay Solutions LLC
Marvin Gee, VP, Head of Research, 3T Biosciences
Huub Gelderblom, Director, Fred Hutch
Hoa Giang, Senior Director of Antibody Engineering, Twist Bioscience
Steve Glavas, Business Developemnt, Magic Bioprocessing
Elena Gontarz, Senior Manager, S&TA, Thermo Fisher Scientific
Davis Goodnight, Senior Scientist, A-Alpha Bio
Marshall Goodwin, Principal Scientist, NysnoBio
Christilyn Graff, SVP, Head of Research, Mosaic Biosciences
David Grandy, Senior Scientist, Merck
Scott Greilach, Senior Research Scientist, Immunis Inc.
Rosa Grenha, Director Protein Biochemistry, Keros Therapeutics
June Guo, VP of AI and ML, Athos Therapeutics Inc
Linlin Guo, Assistant Research Professor of Microbiology & Immunology, Indiana university School of Medicine
Joanna Guo, Senior Scientist, Zentalis
Sanjeev Gupta, Sr. Vice President and Head -Biosimilar (R&D, Mfg. and BD), Ipca Laboratories Ltd
Abhinav Gupta, Senior Machine Learning Scientist, Next Generation Biologics Design, Sanofi
Sunil Gupta, Senior Consultant and Trainer, SASSavvy.com
Rajarsi Gupta, Assistant Professor, Stony Brook Medicine
Adrian Guzman, Co-Founder and CTO, HelioWave Technologies Inc
Ahmed Hamdy, Chairman and Chief Executive Officer, Vincerx Pharma
Marianne Hamilton Lopez, Senior Research Director, Biomedical Innovation, Duke Margolis Center for Health Policy
Trae Hampton, Research Assistant Professor, Texas A&M University
Tzvika Hartman, SVP Computation, Biolojic Design
Net Haskins, Scientist II, Protein Engineering, Amgen
Michael Hedvat, Director, Xencor, Inc.
Jonas Helma-Smets, CSO, Tubulis GmbH
CHRISTOPHER HEPLER, Site Head, RTP, Solvias
Björn Hock, Chief Development Officer, Tubulis GmbH
Jeroen Hofenk, Founder and CSO, Swiftpharma
Kyle Hoffman, Applications Manager, Bioinformatics Solutions Inc
Rob Holgate, Senior Director, Protein Engineering, Abzena
Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard
Changyun Hu, CSO & Co-Founder, Adept Therapeutics Inc
Karin Hughes, SVP, Global Regulatory and Quality, Beaufort
Sophia Humphreys, Executive Director, System Pharmacy, Providence
Anna Hyde, Vice President of Advocacy and Access, Arthritis Foundation
Clayton Irvine, Senior Manager, Oncology Cancer Care, Mayo Clinic
Eswar Iyer, Aikium
Janani Iyer, Product Manager, Absci
Shwetha Iyer, Principal scientist II - Lab head, Formulations, Novartis
Bret Jackson, President, Economic Alliance of Michigan
Vibha Jawa, Executive Director, BMS
Jingjing Jiang, Senior Director, Development Sciences, Bambusa Therapeutics
Joshua Justice, Proteogenomics Scientist, Johnson & Johnson
Mo Kagalwala, Venture Partner, Aquillius
Derrick Katayama, Lead Scientist, Formulation, Samsung Biologics
Anupurna Kaul, Senior Scientist, Amgen
Pravin Kaumaya, Professor, IU
Bruce Keyt, CSO, Multivalent Biosciences
Dikran Khachadourian, Field Application Scientist, Halo Labs
Rachael Kim, CEO, My Comma
Kevin Knopf, Chairman Hematology And Oncology, Highland Hospital
Emilee Knowlton, Senior Immunology Sales Specialist, ProImmune Inc
Srikanth Kotapati, Associate Director, Neurocrine Biosciences
Pascal Krotee, Principal, RiverVest Venture Partners
Zoran Krunic, Sr. Manager Data Science, Amgen
Keiichiro Kushiro, Director of Research, Mucommune
Sam Lai, Professor, Division of Pharmacoengineering and Molecular Pharmaceutics, The University of North Carolina at Chapel Hill
Neal Lambert, Senior Director and Team Lead, Pricing Strategy Biosimilars, pfizer
Jin Lee, Founder, IMIDeology
Isabelle Lehoux, Director, Protein Biochemistry, Gilead Sciences
Steve Lehrer, MD, SBLehrer LLC
Sabrina Leslie, Associate Professor, The University of British Columbia
John Lesnick, Senior Field Application Scientist, Sphere Bio
Matteo Levisetti, Chief Medical Officer, Cue Biopharma, INC
Shawn Levy, SVP of Scientific Affairs, Cellanome
Nathan Lewis, GRA Eminent Scholar and Professor Center for Molecular Medicine Complex Carbohydrate Research Center, University of Georgia
Yinyin Li, Principal Scientist, Genentech
Haining Li, Doctor, UCSD
Sue Lim, Principal, Insight Biologics Consulting
Kathleen Lin, Site Head, LGL, Eli Lilly
John Lippincott, SVP, Therapeutic Discovery Strategies, Alloy Therapeutics
Lippy Lippincott, Senior Vice President of Therapeutic Discovery Strategies, Alloy Therapeutics
Gang Liu, Associate Director, Biointron Biological Inc
Wenshe Liu, Bovay Chair and Professor in Chemistry, Director of Texas A and M Drug Discovery Center, Texas A&M University
Cate Lockhart, Executive Director, Biologics and Biosimilars Collective Intelligence Consortium
Anne Lynch, Research Associate, Hologic
Jianhui Ma, Associate Director, Zentalis Pharmaceuticals
Yuanhui Ma, Senior research scientist I, Gilead Science
Scott Mack, Principal Scientist, SCIEX
Ankit Mahendra, Senior Principal Scientist, Lab Head, Sanofi
Mark Mamula, Professor Of Medicine Rheumatology, Yale University
Jay Mandrekar, Professor Of Biostatistics And Neurology, Mayo Clinic
Cheryl Marcotte, Clinical Quality leader, GSK
Spencer Marsh, Chief Scientific Officer, The Tiny Cargo Company
Nicholas Marshall, Director of Protein Sciences, Invenra Inc
Shamekka Marty, Patient Advocate, National Minority Health Association
Chris Mason, Professor, Cell and Gene Therapy, University College London (UCL)
John Mattison, Operating Partner, Chief Medical Information Officer, Arsenal Capital Partners
Sean McGowan, Vice President, Biosimilars, Amneal Pharmaeuticals
Stanton Mehr, Director of Content, Biosimilars Review & Report
Anu Mehta, Sr. Director, Clinical Programs, AstraZeneca
Matthew Metzger, Alliance and Business Manager, Oxford BioTherapeutics Ltd
Matthew Michelson, Chief Executive Officer, Readout AI
Marco Mirata, Director, Head of Microbial Manufacturing Science and Technology (MSAT), Lonza
Liviu Movileanu, Professor, Department Of Physics, Syracuse University
Savita Nair, Associate Director, Sangamo Therapeutics
Sarfaraz Niazi, PROFESSOR, University of Illinois
Neelakshi Okhade, MD, Kaiser Permanente
Aline Oliveira, Competitive Intelligence Analyst, Institute of Technology on Immunobiologicals (Bio-Manguinhos)
Steve O'Malley, President Petauri Consulting Group, Petauri Health
Yemi Onakunle, Founder And Chief Executive Officer, MabSwitch Inc
Tudor Oprea, Professor, University of New Mexico
Sonia Oskouei, Vice President, Biosimilars and Specialty, sandoz
Vincent Pai, Director, Product Management, Bruker
Joseph Park, Senior Manager, Samsung Bioepis
William Paseman, Founder, rarekidneycancer.org
Bill Paseman, co-founder, rarekidneycancer.org
Ravish Patel, General Manager, Kodo Life Science
Hetal Patel, Vice President, Medical Affairs, Celltrion Healthcare
Lauri Peil, Key Account and Technology Officer, Icosagen
Chad Pettit, Executive Director, Global Government Affairs, Amgen
Salome Philip, CMC Project Manager, Attralus
Chayne Piscitelli, Principal Scientist, Protein Engineering, Zymeworks
Mary Pitman, Staff Research Scientist, AI Sim, Sandbox AQ
Dracey Poore, Director of Biosimilars, Cardinal Health
Patrizia Porazzi, Senior Research Investigator, Haematology and Oncology, University of Pennsylvania
Alejandro Preciado, Sr. Director, Business Development, KBI Biopharma, Inc.
Kamal Puri, CSO, OncoResponse
Alexei Pushechnikov, Chief Technology Officer, Expert Systems
Leon Pybus, Associate Director, FUJIFILM Diosynth Biotechnologies
Steven Quayle, Senior Vice President & Head of Research and Translational Medicine, Cue Biopharma
Samina Qureshi, International Medical Officer, MedDRA MSSO
Maryam Raeeszadeh-Sarmazdeh, Assistant Professor of Chemical Engineering, University of Nevada
Allison Ramiller, Product Manager, Prize Design, XPRIZE
Sathya Ramnath, Sr Manager, Gilead Sciences
Giuseppe Randazzo, Senior Vice President of Sciences and Regulatory Affairs, Association for Accessible Medicines
Udaya Rangaswamy, Director of Translational Biology, Rondo Therapeutics
Jeff Rapp, Director, University of Georgia
Christopher Robertson, Professor of Law, Boston University
Christy Robinson, Principal, MGA
Roelof Rongen, Co-Founder & Board Member, Stealth
Roelof Rongen, CEO, Adolore Biotherapeutics
Mahdi Roohnikan, Business Development Manager, SGS Vitrology
Brandon Ruotolo, Professor, University of Michigan
Dr Md Abu Zafor Sadek, Deputy General Manager, UniMed UniHealth
Giorgio Salciarini, Head of Sales - Technical Business Development, BSP Pharmaceuticals Spa
Harshika Sarbajna, Vice President of Commercial and Head, Global, Alvotech
Michael Sarshad, Managing Director, Syneos
Volker Schellenberger, SVP Research Oncology, Vir Biotechnology, Inc.
Jan Schnitzer, Director, P.R.I.S.M.
Oscar Segurado, Chief Medical Officer, Asc Therapeutics
Alessandro Sette, Professor, La Jolla Institute for Allergy and Immunology
Farah Sheikh, Professor of Medicine, University of California San Diego
Yang Shen, Executive Director of Antibody Engineering, Regeneron Pharmaceuticals
Lei Shi, Senior Vice President, Biointron Biological
Diane Simeone, Director, Moores Cancer Center
Jae Sly, Chief Business Development Officer, Obatala Sciences
Angela Specht, Global Head, BARDA Alliance, Johnson & Johnson
Pawel Stanczak, Director of Process and Drug Product Development, Bora Biologics
Samuel Stimple, Field Application Scientist, Twist Bioscience
Michael Sumner, CMO, Inovio
Adeleh Taghi Khani, Senior Scientist II, Quest Diagnostics
Arun Tailor, Principal Scientist - Drug Development, Genentech
Shreehas Tambe, Chief Executive Officer and Managing Director, Biocon Biologics
Keenan Taylor, Principal Research Scientist I, Abbvie
Andy Tedeschi, Vice President, Market Access and Account Management, Organon
Archana Thakur, Associate Professor, University of Virginia
Aman Thukral, Director -Global Head-Clinical Systems & Digital Operations, Abbvie
Jakub Tomala, Assistant Research Professor, John Hopkins University
Phong Tran, President & CEO, SirnaMed Therapeutics Inc.
Andrew Tsourkas, Bioengineering Professor, University of Pennsylvania
Ariadne Tuckmantel Bido, Senior Scientist, ScopeSys
Ross Turmell, Principal Scientist, Cytiva
Eeshit Dhaval Vaishnav, CEO, Sequome, Inc.
Hans Van Der Vliet, Chief Scientific Officer, LAVA Therapeutics
Leah Villegas, Managing Partner, Aquillius Ventures
Jyothsna Visweswaraiah, Director, Biotherapeutics, Drug Creation, Seismic Therapeutic
Christine von Raesfeld, Board member/advocate, The Light Collective
Sudhakar Voruganti, Director of Business Development - East Coast, Pfanstiehl Inc
Kim Walker, Faculty Director & Graduate Advisor Center for Regulatory Science, San Diego State University
Chao Wang, Staff Scientist, The Scripps Research Institute
Wei Wang, Professor, University of California San Diego
Jenny Wei, Sr. Director, R&D Informatics and Technology, Kite Pharma
Miao Wen, Director, Sutro Biopharma
Kyle Williams, Bioassay Analyst 1, Dendreon Pharmaceuticals LLC
Laura Wingate, Executive Vice President of Education, Support and Advocacy, Crohns and Colitis Foundation of America
David Wood, Professor, Ohio State University
Haoheng (Sandy) Yan, Head of US Regulatory Affairs, Shanghai Henlius Biotech Co., Ltd.
Gene Yeo, Professor, Dept of Cellular and Molecular Medicine, University of California San Diego
Aiying Yu, Senior Scientist-Drug Development, Genentech
Kevin Zen, Senior Director, IGM Biosciences
Samuel Zhang, Chief Business Officer, Gracell Biotechnology
Samuel Zhang, Chief Business Officer, Innovent Biologics, Inc
Jing Zhang, Ass. Project Scientist, University of California San Diego
Yue Zhao, Principal Scientist, Genentech
Xi Zhao, Head, Oncology Bioinformatics, Research and Development, Abbvie
Sheng Zhong, Professor, University of California San Diego
Yu Zhou, Manager, Analytical Development, Millipore Sigma
Alla Zilberman, Vice President, Technical Marketing, Cygnus Technologies Inc
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events